Market Overview

Top 4 Mid-Cap Stocks In The Drugs-Generic Industry With The Highest ROA

Share:
Related AKRX
Earnings Scheduled For February 26, 2015
Jefferies Weighs In On Specialty Pharmaceuticals After Management Meetings, Raises Price Targets On 5 Stocks
Meet IBD's 4 A Stocks With Rising Earnings Estimates (Investor's Business Daily)
Related SLXP
Here's Why CRT Capital Boosted Valeant Pharmaceuticals' Price Target
Valeant Pharmaceuticals Is Kicking Butt, Says Canaccord Genuity
Jazz Pharmaceuticals Tops Q4 Earnings And Tests Buy Point (Investor's Business Daily)

Below are the top mid-cap drugs-generic stocks on the NYSE and the NASDAQ in terms of return on assets.

The trailing-twelve-month return on assets at Akorn (NASDAQ: AKRX) is 13.00%. Akorn's EPS for the same period is $0.46.

The trailing-twelve-month return on assets at Salix Pharmaceuticals (NASDAQ: SLXP) is 6.40%. Salix's revenue for the same period is $1.12 billion.

The trailing-twelve-month return on assets at Mallinckrodt plc (NYSE: MNK) is 2.50%. Mallinckrodt's operating margin for the same period is 9.20%.

The trailing-twelve-month return on assets at Hospira (NYSE: HSP) is 1.00%. Hospira's PEG ratio is 5.78.

Posted-In: Drugs-Generic Industry Mid-Cap ROATrading Ideas

 

Related Articles (AKRX + HSP)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→